Breast metastases from an adrenocorticotropic hormone secreting thymic neuro-endocrine tumor.
Metastases to the breast from non-mammary sites are rare and pose a diagnostic and therapeutic challenge. They can be mistaken for primary breast malignancy, which is much more common. In this case report we describe the clinical, radiological and pathological features of a patient who developed breast metastases from an adrenocorticotropic hormone (ACTH) secreting thymic neuro-endocrine carcinoma. Patient was initially felt to have a primary breast malignancy, however, after further ancillary testing a diagnosis of metastatic thymic neuro-endocrine tumor was made.
Division of Hematology-Oncology, Texas Tech University Health Science Center, Paul L Foster School of Medicine, TX, USA.
Sumit
S
Gaur
Anoop P
AP
Ayyappan
Zeina
Z
Nahleh
D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000328:Adult; D001943:Breast Neoplasms / Q000378:metabolism / Q000556:secondary*; D018278:Carcinoma, Neuroendocrine / Q000556:secondary*; D005260:Female; D006801:Humans; D013953:Thymus Neoplasms / Q000378:metabolism / Q000473:pathology*
D000324:Adrenocorticotropic Hormone
Thymic tumor; breast metastasis; neuroendocrine tumor